Gastrointestinal adverse events - predominantly nausea, vomiting, diarrhea, and constipation - are the most common class effects, occurring in 20%-60% of patients depending on the agent and dose, and are typically of mild-to-moderate severity, dose-dependent, and most prominent during titration
[DOI] [PubMed] [Google Scholar] 44.Jones DP, Go YM
It contains a special ingredient called glutathione
Table 12: Results at Week 24 (LOCF*) in an Active-Controlled Trial of Dapagliflozin Initial Combination Therapy with Metformin HCl Extended-Release in Adults with Type 2 Diabetes Mellitus Dapagliflozin Add-On To Metformin HCl Immediate-Release A total of 546 adult patients with type 2 diabetes mellitus with inadequate glycemic control (HbA1c 7% and 10%) participated in a 24-week, placebo-controlled trial to evaluate dapagliflozin in combination with metformin HCl (NCT00528879)
Book your free consultation by calling (631) 551-5131 at North Shore Medical Wellness on Long Island today and take the first step toward a healthier, happier you
Luaran utama yang dievaluasi ialah HbA1c dan rate of all adverse events
